JPH0427964B2 - - Google Patents

Info

Publication number
JPH0427964B2
JPH0427964B2 JP58094141A JP9414183A JPH0427964B2 JP H0427964 B2 JPH0427964 B2 JP H0427964B2 JP 58094141 A JP58094141 A JP 58094141A JP 9414183 A JP9414183 A JP 9414183A JP H0427964 B2 JPH0427964 B2 JP H0427964B2
Authority
JP
Japan
Prior art keywords
acid
nucleic acid
ulcer
deoxyribonucleic acid
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58094141A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59219235A (ja
Inventor
Osamu Yano
Takashi Kitano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP58094141A priority Critical patent/JPS59219235A/ja
Priority to US06/611,160 priority patent/US4657896A/en
Priority to DE19843418820 priority patent/DE3418820A1/de
Priority to CA000455193A priority patent/CA1222699A/en
Priority to FR8408312A priority patent/FR2547500B1/fr
Priority to GB08413576A priority patent/GB2140689B/en
Publication of JPS59219235A publication Critical patent/JPS59219235A/ja
Publication of JPH0427964B2 publication Critical patent/JPH0427964B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP58094141A 1983-05-30 1983-05-30 消化性潰瘍用剤 Granted JPS59219235A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP58094141A JPS59219235A (ja) 1983-05-30 1983-05-30 消化性潰瘍用剤
US06/611,160 US4657896A (en) 1983-05-30 1984-05-17 Method for the treatment of digestive ulcers
DE19843418820 DE3418820A1 (de) 1983-05-30 1984-05-21 Arzneimittel fuer verdauungsgeschwuer
CA000455193A CA1222699A (en) 1983-05-30 1984-05-25 Pharmaceutical preparation for digestive ulcer
FR8408312A FR2547500B1 (fr) 1983-05-30 1984-05-28 Preparation pharmaceutique pour ulcere du tube digestif
GB08413576A GB2140689B (en) 1983-05-30 1984-05-29 Treating digestive ulcers using dna

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58094141A JPS59219235A (ja) 1983-05-30 1983-05-30 消化性潰瘍用剤

Publications (2)

Publication Number Publication Date
JPS59219235A JPS59219235A (ja) 1984-12-10
JPH0427964B2 true JPH0427964B2 (en, 2012) 1992-05-13

Family

ID=14102101

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58094141A Granted JPS59219235A (ja) 1983-05-30 1983-05-30 消化性潰瘍用剤

Country Status (6)

Country Link
US (1) US4657896A (en, 2012)
JP (1) JPS59219235A (en, 2012)
CA (1) CA1222699A (en, 2012)
DE (1) DE3418820A1 (en, 2012)
FR (1) FR2547500B1 (en, 2012)
GB (1) GB2140689B (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743782B1 (en) * 1987-10-28 2004-06-01 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US6919320B1 (en) 1987-10-28 2005-07-19 Wellstat Therapeutics Corporation Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US6348451B1 (en) 1987-10-28 2002-02-19 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
EP0355131B1 (en) * 1987-10-28 1996-09-04 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US6020322A (en) 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US7169765B1 (en) 1988-10-27 2007-01-30 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US5081997A (en) † 1989-03-09 1992-01-21 Vance Products Incorporated Echogenic devices, material and method
DE69125702T2 (de) * 1990-09-21 1997-11-27 Amgen Inc Enzymatische synthese von oligonukleotiden
DE19516773A1 (de) * 1995-03-11 1996-09-12 Eftag Entstaubung Foerdertech Verwendung von DNA zur Herstellung von Arzneimitteln
KR102247169B1 (ko) * 2014-01-02 2021-05-03 주식회사 파마리서치프로덕트 어류 정소로부터 분리된 디엔에이 단편 혼합물을 포함하는 소화성 궤양의 예방 또는 치료용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4696M (en, 2012) * 1965-06-23 1966-12-26
US3534017A (en) * 1967-03-14 1970-10-13 Kyowa Hakko Kogyo Kk Process for the preparation of nucleoside-5'-diphosphates and triphosphates and mono- and oligo-nucleotidyl-nucleoside-5'-diphosphates and triphosphates
US3626054A (en) * 1967-10-25 1971-12-07 Bard Hamilton Co Inc Lupus erythematosus skin test
CA949562A (en) * 1969-03-17 1974-06-18 Charles L. Fox (Jr.) Silver pyrimidines and silver purines and derivatives thereof
BE757653A (fr) * 1969-10-21 1971-04-16 Ugine Kuhlmann Nouveaux medicaments derives d'acides nucleiques et procedes pour leur preparation
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
FR2201879B2 (en, 2012) * 1972-05-19 1976-01-23 Tixier Georges Fr
GB1440626A (en, 2012) * 1973-05-02 1976-06-23 Farmaceutici Italia
JPS5221570B2 (en, 2012) * 1973-08-30 1977-06-11
US4062949A (en) * 1974-04-30 1977-12-13 Eisai Co., Ltd. Abrin composition of reduced toxicity
FR2353293A1 (fr) * 1976-06-03 1977-12-30 Beljanski Mirko Polyribonucleotides ayant une activite dans la genese des leucocytes et des plaquettes sanguines
NZ198388A (en) * 1980-09-18 1985-05-31 Wellcome Found Dna molecule comprising sequence substantially corresponding to at least part of foot and mouth disease virus rna;transformed host cell;antigen and vaccine
JPS57139096A (en) * 1981-02-21 1982-08-27 Mitsui Toatsu Chem Inc Heat denaturing deoxyribonucleic acid md-011 having antitumor activity and antitumor agent
US4579941A (en) * 1982-08-13 1986-04-01 Mitsuitoatsu Chemicals, Inc. Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent

Also Published As

Publication number Publication date
GB2140689A (en) 1984-12-05
JPS59219235A (ja) 1984-12-10
DE3418820A1 (de) 1984-12-13
FR2547500B1 (fr) 1988-01-08
FR2547500A1 (fr) 1984-12-21
US4657896A (en) 1987-04-14
GB8413576D0 (en) 1984-07-04
DE3418820C2 (en, 2012) 1987-12-17
GB2140689B (en) 1986-12-17
CA1222699A (en) 1987-06-09

Similar Documents

Publication Publication Date Title
US3929994A (en) Anti-inflammatory glycoprotein compositions and method of use
US3855197A (en) Glycoproteins extracted from microorganisms
JPH0427964B2 (en, 2012)
FR2522267A1 (fr) Glycoproteines a activite antitumorale, leur procede de preparation et leur application therapeutique
JP2009535328A5 (en, 2012)
US5166219A (en) Systemic anti-inflammatory treatment
US5194451A (en) Systemic anti-inflammatory treatment
RU2041717C1 (ru) Биологически активное средство, способ его получения и препарат, содержащий указанное средство, и способ использования препарата
CN101020715B (zh) 鹿茸神经生长因子(deer ngf)提取及其制备方法
Simpson Neuropoisons: their pathophysiological actions
JPH01157995A (ja) 鎮痛−抗炎症活性を有するガングリオシドの内部エステル
KR930002010B1 (ko) 당뇨병 치료제
US4666893A (en) Methods of inducing resistance to bacterial and viral infections
WO1992002231A1 (fr) Agent anti-vih
EP1009418B1 (en) Robinia pseudoacacia lectin and its uses
EP0239607A1 (en) Tissue growth regulation
KR930002011B1 (ko) 혈압 조절제
RU2147239C1 (ru) Общеукрепляющее неспецифическое иммуномодулирующее средство
JP2014530223A (ja) 再生性、鎮痛性および／または抗炎症性を有する卵調製物
HK1005168A1 (en) Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident
HK1005168B (en) Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident
US4442087A (en) Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
CN102670528A (zh) 注射用泮托拉唑钠冻干粉组合物及其制备方法
BRPI0706837A2 (pt) uso de compostos epoxidados
AU722200B2 (en) Anti-helicobacter vaccine complex